Comparison of two methods of patient-controlled analgesia through intravenous and thoracic epidural in surgery of esophageal cancer patients

Comparison of two methods of patient-controlled analgesia through intravenous and thoracic epidural to control pain and complications after surgery in esophageal cancer patients at the Cancer Institute of Imam Khomeini Hospital

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200929048879N1

Enrollment

Registered

2020-12-06

Start date

2020-03-19

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Control of pain and complications after surgery in esophageal cancer patients. Chronic cancer pain

Interventions

Intervention 1: Intervention group: Patients who have had a thoracic catheter implanted before the epidural anesthesia and an epidural analgesic pump with a local anesthetic will be inserted around t

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who have referred for esophageal cancer surgery. Patients in the age range of 20 to 80 years who were candidates for esophageal cancer surgery.

Exclusion criteria

Exclusion criteria: Patients with coagulation disorders. Infection of the epidural catheter insertion site Patients with severe hemodynamic disorders. Patients with severe movement disorders. Patients with chest disorders. Patients with neurological disorders. Patients who are addicted to drugs.

Design outcomes

Primary

Measure	Time frame
Control of pain and complications after surgery in patients undergoing esophageal cancer surgery according to the Global Pain Assessment Tool (UPAT). Timepoint: Before and during esophageal cancer surgery and during hospitalization in the ICU. Method of measurement: Using the Global Pain Assessment Tool (UPAT).;Pain score on the second day after esophageal cancer surgery with Global Pain Assessment Tool (UPAT). Timepoint: During hospitalization in the ICU. Method of measurement: Using the Global Pain Assessment Tool (UPAT).;Pain score on the third day after esophageal cancer surgery with Global Pain Assessment Tool (UPAT). Timepoint: During hospitalization in the ICU. Method of measurement: Using the Global Pain Assessment Tool (UPAT).;Determining the length of hospital stay of patients in the ICU. Timepoint: During hospitalization in the ICU until transfer to the surgical ward. Method of measurement: Clinical symptoms of patients.;Extra drug use required based on patients' pain score. Timepoint: After esophageal cancer surgery and during hospitalization in the ICU. Method of measurement: Using the Global Pain Assessment Tool (UPAT).;Quarterly survival rate. Timepoint: After surgery up to three months after discharge from the hospital. Method of measurement: Examination of the patient and questions and answers from the patient.;Systolic blood pressure. Timepoint: During surgery until the patient is discharged from the hospital. Method of measurement: Mercury sphygmomanometer.;Diastolic blood pressure. Timepoint: During surgery until the patient is discharged from the hospital. Method of measurement: Mercury sphygmomanometer.;Count the pulse. Timepoint: During surgery until the patient is discharged from the hospital. Method of measurement: Through standard patient heart rate monitoring.	—

Measure

Time frame

Control of pain and complications after surgery in patients undergoing esophageal cancer surgery according to the Global Pain Assessment Tool (UPAT). Timepoint: Before and during esophageal cancer surgery and during hospitalization in the ICU. Method of measurement: Using the Global Pain Assessment Tool (UPAT).;Pain score on the second day after esophageal cancer surgery with Global Pain Assessment Tool (UPAT). Timepoint: During hospitalization in the ICU. Method of measurement: Using the Global Pain Assessment Tool (UPAT).;Pain score on the third day after esophageal cancer surgery with Global Pain Assessment Tool (UPAT). Timepoint: During hospitalization in the ICU. Method of measurement: Using the Global Pain Assessment Tool (UPAT).;Determining the length of hospital stay of patients in the ICU. Timepoint: During hospitalization in the ICU until transfer to the surgical ward. Method of measurement: Clinical symptoms of patients.;Extra drug use required based on patients' pain score. Timepoint: After esophageal cancer surgery and during hospitalization in the ICU. Method of measurement: Using the Global Pain Assessment Tool (UPAT).;Quarterly survival rate. Timepoint: After surgery up to three months after discharge from the hospital. Method of measurement: Examination of the patient and questions and answers from the patient.;Systolic blood pressure. Timepoint: During surgery until the patient is discharged from the hospital. Method of measurement: Mercury sphygmomanometer.;Diastolic blood pressure. Timepoint: During surgery until the patient is discharged from the hospital. Method of measurement: Mercury sphygmomanometer.;Count the pulse. Timepoint: During surgery until the patient is discharged from the hospital. Method of measurement: Through standard patient heart rate monitoring.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSina Abbasi

Tehran University of Medical Sciences

abbassisina@gmail.com+98 21 6693 6328

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026